Current Treatment Strategies and Risk Stratification for Oral Carcinoma
American Society of Clinical Oncology Educational Book · 2023-05 · (43)
DOI: 10.1200/edbk_389810 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Society of Clinical Oncology Educational Book, 2023-05. Verfasst von Issa Mohamad und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan. Hauptthemen laut MEDLINE: Mouth Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 124 Literaturangaben.
Abstract (Originalsprache)
Management of oral cavity squamous cell carcinoma (OSCC) involves a multidisciplinary team approach. Surgery is ideally the primary treatment option for nonmetastatic OSCC, and less invasive curative surgical approaches are preferred in early-stage disease to minimize surgical-related morbidity. For patients at high risk of recurrence, adjuvant treatment using radiation therapy or chemoradiation is often used. Systemic therapy may also be used in the neoadjuvant setting (for advanced-stage disease with the intent of mandibular preservation) or in the palliative setting (for nonsalvageable locoregional recurrence and/or distant metastases). Patient involvement in treatment decision is the key for patient-driven management, particularly in clinical situation with poor prognosis, for example, early postoperative recurrence before planned adjuvant therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
- Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, Homi Bhabha National Institute, Mumbai, India.
- Department of Radiation Oncology, Kuwait Cancer Control Center, Kuwait.
- Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
ORCID-Profile: Ali Hosni
Zitieren
APA
Mohamad, I., Glaun, M. D. E., Prabhash, K., Busheri, A., Lai, S. Y., Noronha, V., & Hosni, A. (2023). Current Treatment Strategies and Risk Stratification for Oral Carcinoma. American Society of Clinical Oncology Educational Book. https://doi.org/10.1200/edbk_389810
Vancouver
Mohamad I, Glaun MDE, Prabhash K, Busheri A, Lai SY, Noronha V, et al. Current Treatment Strategies and Risk Stratification for Oral Carcinoma. American Society of Clinical Oncology Educational Book. 2023. doi:10.1200/edbk_389810
BibTeX
@article{Mohamad2023,
author = {Mohamad, Issa and Glaun, Mica D E and Prabhash, Kumar and Busheri, Ahmed and Lai, Stephen Y and Noronha, Vanita and Hosni, Ali},
title = {Current Treatment Strategies and Risk Stratification for Oral Carcinoma},
journal = {American Society of Clinical Oncology Educational Book},
year = {2023},
number = {43},
doi = {10.1200/edbk_389810}
}
EUVIMED